TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion
(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates. Read More